Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9861406rdf:typepubmed:Citationlld:pubmed
pubmed-article:9861406lifeskim:mentionsumls-concept:C0024530lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0063695lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0056182lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C1416402lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:9861406lifeskim:mentionsumls-concept:C0238606lld:lifeskim
pubmed-article:9861406pubmed:issue3lld:pubmed
pubmed-article:9861406pubmed:dateCreated1998-12-31lld:pubmed
pubmed-article:9861406pubmed:abstractTextMany genes have been shown to be involved in host susceptibility to the severe forms of Plasmodium falciparum malaria but it is likely that a large number of malaria-susceptibility genes remain to be determined. We conducted a large case-control study of children with the severe forms of this disease-cerebral malaria and severe malarial anaemia--to attempt to identify these genes. Over 1200 children in The Gambia were typed for polymorphisms of the intercellular adhesion molecule 1 (ICAM-1), complement receptor 1 (CR-1) and interleukin 1 receptor antagonist (IL-IRA) genes. None of the polymorphisms typed was significantly associated with severe disease. These data differed significantly from the results of a previous study (Chi 2 = 8.81; P = 0.003) in which the ICAM-1 gene polymorphism was shown to be significantly associated with cerebral malaria in a case-control study of 547 subjects in Kenya. This suggests that there may be heterogeneity in genetic susceptibility to this condition between these 2 African populations.lld:pubmed
pubmed-article:9861406pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9861406pubmed:languageenglld:pubmed
pubmed-article:9861406pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9861406pubmed:citationSubsetIMlld:pubmed
pubmed-article:9861406pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9861406pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9861406pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9861406pubmed:statusMEDLINElld:pubmed
pubmed-article:9861406pubmed:issn0035-9203lld:pubmed
pubmed-article:9861406pubmed:authorpubmed-author:HillA VAVlld:pubmed
pubmed-article:9861406pubmed:authorpubmed-author:BellamyRRlld:pubmed
pubmed-article:9861406pubmed:authorpubmed-author:KwiatkowskiDDlld:pubmed
pubmed-article:9861406pubmed:issnTypePrintlld:pubmed
pubmed-article:9861406pubmed:volume92lld:pubmed
pubmed-article:9861406pubmed:ownerNLMlld:pubmed
pubmed-article:9861406pubmed:authorsCompleteYlld:pubmed
pubmed-article:9861406pubmed:pagination312-6lld:pubmed
pubmed-article:9861406pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:meshHeadingpubmed-meshheading:9861406-...lld:pubmed
pubmed-article:9861406pubmed:articleTitleAbsence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population.lld:pubmed
pubmed-article:9861406pubmed:affiliationWellcome Trust Centre for Human Genetics, Oxford, UK. richard@well.ox.ac.uklld:pubmed
pubmed-article:9861406pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9861406pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9861406lld:pubmed